Skip to main content
Erschienen in: BMC Geriatrics 1/2024

Open Access 01.12.2024 | Research

Effect of neutrophil to lymphocyte ratio on prognosis of elderly patients with severe sepsis combined with diabetes mellitus

verfasst von: Shan Jin, Jun-bin Yin, Wei Li, Li-li Zang

Erschienen in: BMC Geriatrics | Ausgabe 1/2024

Abstract

Background

To investigate the predictive value of neutrophil-to-lymphocyte ratio (NLR) in the short-term prognosis of elderly patients with severe sepsis combined with diabetes mellitus (DM).

Methods

The clinical data of 162 elderly patients with severe sepsis combined with DM from January 2018 to December 2022 were retrospectively collected. These patients were divided into a survival group (n = 104) and a death group (n = 58) according to 90-day prognosis. The number of neutrophils, lymphocytes, and NLR were compared. The optimal cut-off value for NLR to predict 90-day prognosis in elderly patients with severe sepsis combined with DM was determined using Receiver Operator Characteristic (ROC) curves, and the patients were divided into high and low NLR groups depending on the optimal cut-off value. The Kaplan-Meier method was used to plot the survival curves of the high and low NLR groups. Risk factors for the 90-day death in elderly patients with severe sepsis combined with DM were analyzed by a multivariate cox regression model.

Results

There were no significant differences in gender, age, history of hypertension and hyperlipidemia, intensive care unit (ICU) stay, duration of mechanical ventilation, and oxygenation index between the survival group and death group (p > 0.05). However, acute physiological and chronic health evaluation II (APACHE II) scores, and sepsis-related organ failure assessment (SOFA) scores were significantly lower in the survival group compared with the death group (p < 0.05). In the survival group, neutrophils counts and NLR were much lower than those in the death group, while lymphocytes counts were much higher (p < 0.05). ROC curves showed that the optimal cut-off value for NLR to predict 90-day mortality in elderly patients with severe sepsis combined with DM was 3.482. Patients were divided into high NLR and low NLR groups based on whether NLR was ≥ 3.482. In terms of the log-rank test results, patients in the low NLR group had a significantly higher 90-day survival rate than those in the high NLR group (Logrank χ2 = 8.635, p = 0.003). The multivariate cox regression model showed that the length of ICU stay longer than 15 days and NLR ≥ 3.482 were independent risk factors for 90-day prognosis in elderly patients with severe sepsis combined with DM.

Conclusion

NLR ≥ 3.482 can be used to predict whether poor prognosis occurs in the short term after illness in elderly patients with severe sepsis combined with DM, and has good assessment value.
Hinweise

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Background

Sepsis is a condition caused by a disturbance in the internal environment of the body in reaction to severe infection. In severe cases, the disease can even develop into multiple organ dysfunction syndrome (MODS). Septic patients require comprehensive treatment measures, and lack of early intervention and treatment can lead to death [1]. Each year, millions of people are treated for sepsis [2] and died as a result. A large meta-analysis in 2020 showed that the mortality rate of septic patients exceeded 20% [3]. However, the pathogenesis of sepsis is not yet fully understood. Existing studies have found that systemic inflammatory reaction syndrome (SIRS) can manifest itself early in sepsis, suggesting that sepsis is fundamentally an immune dysfunctional process [4]. When a pathogen invades the organism, the immune system is activated but unable to clear the pathogen. If the immune system is overactivated, a large number of pro-inflammatory mediators will be released to trigger an inflammatory storm [5]. Therefore, assessing the immune system in septic patients will help physicians to take the most active and effective treatment. Neutrophils and lymphocytes are the most important organismal immune cells involved in the whole process of sepsis [6]. The neutrophil-to-lymphocyte ratio (NLR) has been revealed to indicate the prognostic status of septic patients [7].
However, NLR is mostly used to predict the prognosis of all septic patients. As for elderly diabetic patients with high risk of sepsis, the prognostic value of NLR has not been clearly explored. Advanced age or/and diabetes are poor prognostic factors for sepsis, with the elderly accounting for more than 60% of cases [8]. Moreover, the atypical symptoms in elderly patients may delay diagnosis [9, 10]. Diabetes, more seriously, can aggravate sepsis [11]. Therefore, finding prognostic indicators for the detection of severe sepsis in elderly patients with diabetes mellitus would be crucial for their clinical management. In this study, we investigated the predictive value of NLR in the prognosis of 162 elderly patients with severe sepsis combined with diabetes mellitus from our hospital by retrospectively analyzing their clinical data.

Subjects and methods

Study subjects

A retrospective collection of 162 elderly patients with severe sepsis combined with diabetes mellitus diagnosed and treated in our hospital from January 2018 to December 2022 was performed. These patients were divided into a survival group (n = 104) and a death group (n = 58) according to the 90-day prognosis. Inclusion criteria: patients with (1) age of ≥ 60 years; (2) a history of diabetes mellitus; and (3) a diagnosis of severe sepsis. Exclusion criteria: (1) those who died within 24 h after admission; (2) those with a leukocyte count < 0.5 × 109/L; (3) those with severe underlying diseases; (4) those with serious diseases of organs such as the heart and kidney; (5) those with autoimmune diseases, hemopathy, immunodeficiency who received chemotherapy and treatment with immunosuppressants or monoclonal antibodies. This study was approved by the ethics committee of Shandong Province 960th Hospital of the People’s Liberation Army (2023-058). All patients were fully informed and signed the consent form for donation of biological sample and information at the time of admission.

Data collection

Basic information: gender, age, comorbidity (hypertension, hyperlipidemia), acute physiological and chronic health evaluation II (APACHE II) score, sepsis-related organ failure assessment (SOFA) score, intensive care unit (ICU) stay, duration of mechanical ventilation, and oxygenation index were collected for all included patients.
Neutrophils, lymphocytes and NLR: Peripheral venous blood was collected on the day the patients were admitted to the hospital, and routine blood tests were performed using a WD.5000 Auto Hematology Analyzer (Jilin WEIER Medical Equipment Co., ltd.). Neutrophil counts and lymphocyte counts were recorded. NLR = neutrophil count/lymphocyte count.
Basic vital signs: The basic vital signs including respiratory rate, heart rate, and mean arterial pressure (MAP) were collected on the day of admission, day 3, day 5, and day 7 for both groups.

Statistical analysis

The statistical software GraphPad® 9.5 was used. Continuous variables were expressed as mean ± standard deviation (SD), and the t-test was performed to compare the differences between two groups; categorical variables were expressed as n (%), and the chi-square test was used to compare the differences between two groups. Receiver Operator Characteristic (ROC) curves were plotted to determine the optimal cut-off value for NLR to predict 90-day mortality in elderly patients with severe sepsis in combination with diabetes. The obtained cut-off value was applied to grouping (high NLR and low NLR groups). The Kaplan-Meier method was used to plot survival curves. Hypothesis testing was performed to examine the survival curves of the high NLR and low NLR groups using the log-rank test. A multivariate cox regression model was contracted to analyze the risk factors for the 90-day mortality in elderly patients with severe sepsis combined with diabetes. P < 0.05 was considered to be statistically significantly different. In this study, we set the level of significance (two-sided) as ɑ = 0.05 and effect size d = 0.5. The power value was calculated using G*Power 3.1 software as 0.858.

Results

Basic information of patients in both groups

A total of 162 elderly patients with severe sepsis and comorbid diabetes mellitus who met the inclusion criteria were collected at our hospital from January 2018 to December 2022 and were divided into a survival group (n = 104) and a death group (n = 58) depending on the 90-day prognosis of the patients, Flow chart of grouping is shown in Fig. 1. The collection results are shown in Table 1. The gender (p = 0.997), age (p = 0.167), history of hypertension (p = 0.302), the history of hyperlipidemia (p = 0.55), ICU stay (p = 0.156), duration of mechanical ventilation (p = 0.346) and oxygenation index (p = 0.957) were not significantly different in the two groups (p > 0.05). However, APACHE II score (37.67 ± 4.09 vs. 39.55 ± 5.17; p = 0.012) and SOFA score (8.51 ± 2.91 vs. 9.66 ± 2.31; p = 0.011) were much lower in the survival group compared with the death group.
Table 1
Basic information of patients in both groups
 
Survival group (n = 104)
Death group (n = 58)
X2/t
p-value
Age (years)
70.81 ± 4.00
71.74 ± 4.28
-1.390
0.167
Gender (%)
  
0.000
0.997
men
61(58.7)
34(58.6)
  
women
43(41.3)
24(41.4)
  
Hypertension (%)
  
1.067
0.302
no
50(48.1)
23(39.7)
  
yes
54(51.9)
35(60.3)
  
Hyperlipidemia (%)
  
3.668
0.055
no
68(65.4)
29(50.0)
  
yes
36(34.6)
29(50.0)
  
ICU stay (days)
7.24 ± 2.67
7.90 ± 3.04
-1.425
0.156
Mechanical ventilation (days)
3.49 ± 0.97
3.34 ± 0.89
0.946
0.346
Oxygenation index
239.17 ± 17.83
239 ± 22.71
0.054
0.957
APACHEII score
37.67 ± 4.09
39.55 ± 5.17
-2.545
0.012
SOFA score
8.51 ± 2.91
9.66 ± 2.31
-2.575
0.011
Values are expressed as mean ± SD or number (%). ICU: intensive care unit; APACHE II: acute physiological and chronic health evaluation II; SOFA: sepsis-related organ failure assessment

Comparison of neutrophil count, lymphocyte count and neutrophil to lymphocyte ratio (NLR) in the two groups

The results are shown in Table 2; Fig. 2. The survival group showed much lower neutrophil counts (9.09 ± 2.11 vs. 10.15 ± 2.04; p = 0.002) and NLR (3.01 ± 1.00 vs. 3.68 ± 1.16; p < 0.001) than the death group, while much higher lymphocyte counts (3.23 ± 0.86 vs. 2.90 ± 0.63, p = 0.011).
Table 2
Comparison of neutrophil count, lymphocyte count and NLR in the two groups
Groups
n
Neutrophil count (109/L)
Lymphocyte count (109/L)
NLR
Survival group
104
9.09 ± 2.11
3.23 ± 0.86
3.01 ± 1.00
Death group
58
10.15 ± 2.04
2.90 ± 0.63
3.68 ± 1.16
t
 
-3.107
2.563
-3.893
p-value
 
0.002
0.011
< 0.001
Values are expressed as mean ± SD. NLR: neutrophil to lymphocyte ratio

Predictive value of NLR for 90-day prognosis in elderly patients with sepsis combined with diabetes mellitus

Because NLR was significantly different in the survival and death groups, we plotted ROC curves to calculate the optimal cutoff value for NLR to predict 90-day mortality in elderly patients with severe sepsis combined with diabetes mellitus. As a result, we obtained that the optimal cutoff value was 3.482, and that the sensitivity, specificity, area under curve (AUC), positive predictive value and negative predictive value were 50.0%, 75.0%, 0.669 (p < 0.001), 52.7% and 72.9%, respectively (Table 3; Fig. 3).
Table 3
Predictive value of NLR on 90-day prognosis of sepsis in elderly patients with sepsis combined with diabetes mellitus
 
AUC
95%CI
p-value
Sensitivity (%)
Specificity
(%)
Positive predictive value (%)
Negative predictive value (%)
Cutoff value
NLR
0.669
0.583–0.754
< 0.001
50.0
75.0
52.7
72.9
3.482
NLR: neutrophil to lymphocyte ratio; AUC: area under curve; CI: confidence interval;

Differences in basic vital signs between the high NLR and low NLR groups

As shown in Table 4, the optimal cut-off value for NLR to predict 90-day mortality in patients was 3.482, and the patients were divided into high NLR and low NLR groups based on the optimal cut-off value. On the first day of admission, there was no statistically significant difference in respiratory rate (p = 0.658), MAP (p = 0.433) and heart rate (p = 0.189) between the two groups. On days 3, 5, and 7, compared with the first day, heart rate (day 3, 5, 7, p < 0.001) and respiratory rate (day 3, p = 0.026; day 5 and day 7, p < 0.001) decreased and MAP (day 3, 5, 7, p < 0.001) increased in the low NLR group with statistically significant differences (p < 0.05), while heart rate (day 3, p = 0.017; day 5 and day 7, p < 0.001) and respiratory rate (day 3, 5, 7, p < 0.001) increased obviously in the high NLR group. However, the differences in MAP in the high NLR group on days 3 (p = 0.999), 5 (p = 0.683) and 7 (p = 0.067) were not statistically significant when compared with day 1. The differences in respiratory rate, MAP, and heart rate between the two groups were statistically significant (p < 0.001) on days 3, 5, and 7 (Fig. 4).
Table 4
Differences in basic vital signs between the high NLR and low NLR groups
Variables
Groups
Day 1
Day 3
Day 5
Day 7
Respiratory rate (breath/min)
Low NLR group
(n = 107)
25.86 ± 2.12
25.23 ± 1.99*
23.21 ± 1.97**
20.13 ± 2.04**
High NLR group
(n = 55)
25.71 ± 1.90
27.18 ± 1.96**
28.85 ± 1.85**
31.24 ± 2.04**
 
t
0.444
-5.921
-17.628
-32.805
 
p-value
0.658
< 0.001
< 0.001
< 0.001
MAP (mmHg)
Low NLR group
(n = 107)
70.08 ± 4.80
73.67 ± 5.05**
75.06 ± 5.29**
77.81 ± 4.89**
High NLR group
(n = 55)
69.42 ± 5.66
69.51 ± 5.01
68.53 ± 5.35
67.25 ± 4.87
 
t
0.787
4.982
7.406
13.040
 
p-value
0.433
< 0.001
< 0.001
< 0.001
Heart rate (beat/min)
Low NLR group
(n = 107)
94.90 ± 3.45
92.11 ± 3.43**
85.90 ± 3.62**
81.37 ± 3.51**
High NLR group
(n = 55)
94.18 ± 2.89
95.58 ± 3.15*
97.71 ± 3.14**
102.96 ± 3.10**
 
t
1.318
-6.256
-20.556
-38.509
 
p-value
0.189
< 0.001
< 0.001
< 0.001
Values are expressed as mean ± SD. MAP: mean arterial pressure; *p < 0.05, **p < 0.01, vs. Day 1

Kaplan-Meier curves of patients in the high NLR and low NLR groups

The overall survival of patients in the high NLR group was 69.5 months, with a 90-day survival rate of 36.5%; the overall survival of patients in the low NLR group was 77.5 months, with a 90-day survival rate of 65.6%. The log-rank test results showed that the low NLR group exhibited a much higher 90-day survival rate than that of the high NLR group, and the difference was statistically significant (Logrank χ2 = 8.635, p = 0.003) (Fig. 5; Table 5).
Table 5
Survival analysis results of the high NLR group and low NLR group
Groups
Total
Event count
OS
95%CI
Logrank X2
p-value
Low NLR group
107
29
77.5
73.341–81.680
8.635
0.003
High NLR group
55
29
69.5
63.962–75.038
  
OS: overall survival; CI: confidence interval: NLR: neutrophil to lymphocyte ratio

Risk factors for the 90-day death in elderly patients with severe sepsis in combination with diabetes mellitus

Further, we used COX regression analysis to measure the impact of clinical factors on the risk of death. Hazard ratio (HR) values were used to express the ratio of the risk of death. The NLR grouping and the underlying clinical factors of the patients were included in the Cox univariate analysis. It was discovered that the APACHE II score, SOFA score, ICU stay, and NLR grouping were correlated with the 90-day death in elderly patients with severe sepsis in combination with diabetes mellitus. Further Cox multifactor analysis yielded that NLR ≥ 3.482 (HR = 2.001, 95% confidence interval [CI]: 1.183–3.384, p = 0.010) and ICU stay ≥ 15 d (HR = 1.899, 95% CI: 1.08–3.34, p = 0.026) could be used as independent risk factors for 90-day mortality in those patients (Table 6).
Table 6
Risk factors for the 90-day death in elderly patients with severe sepsis in combination with diabetes mellitus
 
Single-factor
Multi-factor
HR(95%CI)
p-value
HR(95%CI)
p-value
Age
1.034(0.969–1.103)
0.313
  
Gender
1.039(0.616–1.752)
0.887
  
ICU stay
1.045(0.960–1.139)
0.307
  
Hospital saty
2.157(1.246–3.733)
0.006
1.899 (1.08–3.34)
0.026
Hypertension
1.224(0.723–2.072)
0.452
  
Hyperlipidemia
1.632(0.975–2.731)
0.062
  
Mechanical ventilation
0.878(0.664–1.162)
0.363
  
Oxygenation index
0.997(0.984–1.011)
0.698
  
APACHEII score
1.067(1.006–1.131)
0.030
1.052(0.991–1.117)
0.098
SOFA score
1.143(1.040–1.255)
0.005
1.083(0.980–1.197)
0.118
NLR grouping
2.124(1.267–3.560)
0.004
2.001(1.183–3.384)
0.010
ICU: intensive care unit; APACHE II: acute physiological and chronic health evaluation II; SOFA: sepsis-related organ failure assessment; NLR: neutrophil to lymphocyte ratio; HR: hazard ratio; CI: confidence interval

Discussion

Severe sepsis is a severe infectious state that has a negative impact on patient survival, while diabetic patients have a significantly higher propensity to develop infections than the general population. Therefore, early assessment of the disease progression will influence the ultimate level of prognosis [12, 13]. In this study, we retrospectively analyzed the clinical data of 162 elderly patients with severe sepsis in combination with diabetes mellitus, and the patients were divided into survival and death groups based on their 90-day prognosis. Comprehensive analysis revealed that the APACHE II and SOFA scores of patients in the survival group were significantly lower than those in the death group. Studies have shown that the APACHE II score and SOFA score are independent risk factors for patients with sepsis [14]. A meta-analysis confirmed that septic patients who developed acute respiratory distress syndrome (ARDS) had significantly higher APACHE-II and SOFA scores than non-ARDS patients [15]. This is consistent with our findings, which suggest that APACHE-II and SOFA scores are important prognostic indicators of death in critically ill patients.
Furthermore, we found that patients in the survival group had significantly lower NLR than those in the death group. Patients with high NLR responded more poorly to treatment. And it was challenging to lower heart rate and respiratory rate, as well as elevate MAP during treatment to maintain the basic vital signs. The difference in NLR between the death and survival groups was mainly attributed to the higher neutrophil and lower lymphocyte levels in the death group. This phenomenon was also discovered in earlier investigations of all septic patients [7, 16]. Our results suggest that NLR is of prognostic significance in elderly patients with severe sepsis in combination with diabetes mellitus. A rise in neutrophil count is often accompanied by a fall in lymphocyte count [17]. Patients may experience a mismatch between elevated neutrophil numbers and the severity of infection in some specific circumstances, such as when they are combined with cachexia or immunosuppression [18]. In contrast, NLR reflects the online dynamic relationship between intrinsic (neutrophils) and adaptive cellular immune responses (lymphocytes) in disease and various pathologic states [19]. A retrospective analysis by Sun et al. demonstrated that NLR is essential for the early detection of sepsis induced by diabetic foot ulcers and is an independent predictive marker of their prognosis [20]. Hence, NLR is a more comprehensive and reliable predictor than neutrophil count alone.
Based on the above results, we further analyzed NLR. ROC curve analysis showed that the AUC of NLR for predicting 90-day mortality in elderly patients with severe sepsis in combination with diabetes mellitus was 0.669. Although the AUC value was not high, it was greater than 0.5 and significantly different, which suggests that NLR has some value in predicting 90-day mortality in patients. Subsequently, we found the most appropriate cutoff value of 3.482, at which point the specificity (75%) was higher than the sensitivity (50%). These results show NLR predicts a low misdiagnosis rate for patients who experience death. Further, patients were divided into high and low NLR groups based on whether NLR was ≥ 3.482. Multivariate cox regression analysis results showed that NLR ≥ 3.482 was an independent risk factor for 90-day prognosis in elderly patients with severe sepsis in combination with diabetes mellitus. However, APACHE-II and SOFA scores were not significantly associated with the occurrence of death. As for other studies, NLR level in normal population is found to be generally 1.6–1.7 [21, 22]. Our study uncovered that NLR ≥ 3.482 indicated poor prognosis in elderly patients with sepsis in combination with diabetes mellitus. The NLR is greater according to the results of previous studies on the predictive value of NLR in sepsis, with half of the studies suggesting that NLR could reach 10 [23]. We speculate that this may be due to the fact that the subjects in this study were elderly diabetic patients with worse basal immune levels. NLR levels considered acceptable in the general population are already predictive of poor prognosis in the high-risk population. It is generally accepted that as people age, their immune systems weaken, and they become more vulnerable to infections. Unfortunately, the effects of age on neutrophils and lymphocytes are not yet fully understood. Moreover, the immune cell function is similarly altered with age [24, 25]. The relationship between NLR and diabetic complications has been demonstrated. To be more precise, a high NLR (or neutrophil count) in hyperglycemic conditions is correlated with the thrombosis [26] and susceptibility to sepsis [27] in mouse models. An association between high NLR and complications in diabetic patients was also discovered in epidemiological statistics [28]. All of these results imply that more stringent observed indicators should be used for the elderly diabetic patients, rather than those used for the general population.
There are some limitations to this study. Firstly, this was a a single-center study, and no external validation of the results was done. In the future, external data should be used for validation. Secondly, this study only investigated the short-term mortality of patients. Previous studies have reported the impact of sepsis on the long-term prognosis of patients. Therefore, patients should receive longer-term follow-up. Finally, the underlying disease causing sepsis may differ between patients. It is best to prevent infections from different sources in various diseases.

Conclusion

NLR ≥ 3.482 has good assessment value and should be encouraged in clinical practice since it can effectively predict poor short-term prognosis in elderly patients with severe sepsis in combination with diabetes mellitus.

Acknowledgements

Not applicable.

Declarations

This study was approved by the ethics committee of Shandong Province 960th Hospital of the People’s Liberation Army (2023-058). All patients were fully informed and signed the consent form for donation of biological sample and information at the time of admission.
Not applicable.

Competing interests

The authors declare no competing interests.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
3.
Zurück zum Zitat Fleischmann-Struzek C, et al. Incidence and mortality of hospital- and ICU-treated sepsis: results from an updated and expanded systematic review and meta-analysis. Intensive Care Med. 2020;46(8):1552–62.CrossRefPubMedPubMedCentral Fleischmann-Struzek C, et al. Incidence and mortality of hospital- and ICU-treated sepsis: results from an updated and expanded systematic review and meta-analysis. Intensive Care Med. 2020;46(8):1552–62.CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Qiu P, Liu Y, Zhang J. Review: the Role and mechanisms of Macrophage Autophagy in Sepsis. Inflammation. 2019;42(1):6–19.CrossRefPubMed Qiu P, Liu Y, Zhang J. Review: the Role and mechanisms of Macrophage Autophagy in Sepsis. Inflammation. 2019;42(1):6–19.CrossRefPubMed
5.
Zurück zum Zitat Bosmann M, Ward PA. The inflammatory response in sepsis. Trends Immunol. 2013;34(3):129–36.CrossRefPubMed Bosmann M, Ward PA. The inflammatory response in sepsis. Trends Immunol. 2013;34(3):129–36.CrossRefPubMed
7.
Zurück zum Zitat Buonacera A et al. Neutrophil to lymphocyte ratio: an emerging marker of the relationships between the Immune System and diseases. Int J Mol Sci, 2022. 23(7). Buonacera A et al. Neutrophil to lymphocyte ratio: an emerging marker of the relationships between the Immune System and diseases. Int J Mol Sci, 2022. 23(7).
8.
9.
Zurück zum Zitat Carey IM, et al. Risk of infection in type 1 and type 2 diabetes compared with the General Population: a matched cohort study. Diabetes Care. 2018;41(3):513–21.ADSCrossRefPubMed Carey IM, et al. Risk of infection in type 1 and type 2 diabetes compared with the General Population: a matched cohort study. Diabetes Care. 2018;41(3):513–21.ADSCrossRefPubMed
11.
Zurück zum Zitat Frydrych LM, et al. Obesity and type 2 diabetes mellitus drive immune dysfunction, infection development, and sepsis mortality. J Leukoc Biol. 2018;104(3):525–34.CrossRefPubMed Frydrych LM, et al. Obesity and type 2 diabetes mellitus drive immune dysfunction, infection development, and sepsis mortality. J Leukoc Biol. 2018;104(3):525–34.CrossRefPubMed
13.
Zurück zum Zitat Akinosoglou K, et al. Diabetes on sepsis outcomes in non-ICU patients: a cohort study and review of the literature. J Diabetes Complications. 2021;35(1):107765.CrossRefPubMed Akinosoglou K, et al. Diabetes on sepsis outcomes in non-ICU patients: a cohort study and review of the literature. J Diabetes Complications. 2021;35(1):107765.CrossRefPubMed
14.
Zurück zum Zitat Liu C et al. SOFA Score in relation to Sepsis: Clinical Implications in Diagnosis, Treatment, and Prognostic Assessment Comput Math Methods Med, 2022. 2022: p. 7870434. Liu C et al. SOFA Score in relation to Sepsis: Clinical Implications in Diagnosis, Treatment, and Prognostic Assessment Comput Math Methods Med, 2022. 2022: p. 7870434.
15.
Zurück zum Zitat Mayow AH, et al. A systematic review and Meta-analysis of Independent predictors for Acute respiratory distress syndrome in patients presenting with Sepsis. Cureus. 2023;15(4):e37055.PubMedPubMedCentral Mayow AH, et al. A systematic review and Meta-analysis of Independent predictors for Acute respiratory distress syndrome in patients presenting with Sepsis. Cureus. 2023;15(4):e37055.PubMedPubMedCentral
16.
Zurück zum Zitat Spoto S et al. Diagnostic accuracy and Prognostic Value of Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios in septic patients outside the Intensive Care Unit. Med (Kaunas), 2021. 57(8). Spoto S et al. Diagnostic accuracy and Prognostic Value of Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios in septic patients outside the Intensive Care Unit. Med (Kaunas), 2021. 57(8).
17.
Zurück zum Zitat Djordjevic D et al. Neutrophil-to-Lymphocyte Ratio, Monocyte-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and Mean Platelet Volume-to-Platelet Count Ratio as Biomarkers in Critically Ill and Injured Patients: Which Ratio to Choose to Predict Outcome and Nature of Bacteremia? Mediators Inflamm, 2018. 2018: p. 3758068. Djordjevic D et al. Neutrophil-to-Lymphocyte Ratio, Monocyte-to-Lymphocyte Ratio, Platelet-to-Lymphocyte Ratio, and Mean Platelet Volume-to-Platelet Count Ratio as Biomarkers in Critically Ill and Injured Patients: Which Ratio to Choose to Predict Outcome and Nature of Bacteremia? Mediators Inflamm, 2018. 2018: p. 3758068.
18.
Zurück zum Zitat Shahini A, et al. Ameliorating the hallmarks of cellular senescence in skeletal muscle myogenic progenitors in vitro and in vivo. Sci Adv. 2021;7(36):eabe5671.ADSCrossRefPubMedPubMedCentral Shahini A, et al. Ameliorating the hallmarks of cellular senescence in skeletal muscle myogenic progenitors in vitro and in vivo. Sci Adv. 2021;7(36):eabe5671.ADSCrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Zahorec R. Neutrophil-to-lymphocyte ratio, past, present and future perspectives. Bratisl Lek Listy. 2021;122(7):474–88.PubMed Zahorec R. Neutrophil-to-lymphocyte ratio, past, present and future perspectives. Bratisl Lek Listy. 2021;122(7):474–88.PubMed
20.
Zurück zum Zitat Sun B, et al. Clinical value of neutrophil-to-lymphocyte ratio and prognostic nutritional index on prediction of occurrence and development of diabetic foot-induced sepsis. Front Public Health. 2023;11:1181880.CrossRefPubMedPubMedCentral Sun B, et al. Clinical value of neutrophil-to-lymphocyte ratio and prognostic nutritional index on prediction of occurrence and development of diabetic foot-induced sepsis. Front Public Health. 2023;11:1181880.CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Jiang J, et al. The neutrophil-lymphocyte count ratio as a diagnostic marker for bacteraemia: a systematic review and meta-analysis. Am J Emerg Med. 2019;37(8):1482–9.CrossRefPubMed Jiang J, et al. The neutrophil-lymphocyte count ratio as a diagnostic marker for bacteraemia: a systematic review and meta-analysis. Am J Emerg Med. 2019;37(8):1482–9.CrossRefPubMed
23.
Zurück zum Zitat Huang Z, et al. Prognostic value of neutrophil-to-lymphocyte ratio in sepsis: a meta-analysis. Am J Emerg Med. 2020;38(3):641–7.CrossRefPubMed Huang Z, et al. Prognostic value of neutrophil-to-lymphocyte ratio in sepsis: a meta-analysis. Am J Emerg Med. 2020;38(3):641–7.CrossRefPubMed
24.
Zurück zum Zitat Jackaman C, et al. Aging and cancer: the role of macrophages and neutrophils. Ageing Res Rev. 2017;36:105–16.CrossRefPubMed Jackaman C, et al. Aging and cancer: the role of macrophages and neutrophils. Ageing Res Rev. 2017;36:105–16.CrossRefPubMed
25.
Zurück zum Zitat Tomay F, et al. Aged neutrophils accumulate in lymphoid tissues from healthy elderly mice and infiltrate T- and B-cell zones. Immunol Cell Biol. 2018;96(8):831–40.CrossRefPubMed Tomay F, et al. Aged neutrophils accumulate in lymphoid tissues from healthy elderly mice and infiltrate T- and B-cell zones. Immunol Cell Biol. 2018;96(8):831–40.CrossRefPubMed
26.
Zurück zum Zitat Gauer JS, Ajjan RA, Ariens RAS. Platelet-Neutrophil Interaction and Thromboinflammation in Diabetes: considerations for Novel Therapeutic approaches. J Am Heart Assoc. 2022;11(20):e027071.CrossRefPubMedPubMedCentral Gauer JS, Ajjan RA, Ariens RAS. Platelet-Neutrophil Interaction and Thromboinflammation in Diabetes: considerations for Novel Therapeutic approaches. J Am Heart Assoc. 2022;11(20):e027071.CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Insuela DBR, et al. Glucagon reduces Neutrophil Migration and increases susceptibility to Sepsis in Diabetic mice. Front Immunol. 2021;12:633540.CrossRefPubMedPubMedCentral Insuela DBR, et al. Glucagon reduces Neutrophil Migration and increases susceptibility to Sepsis in Diabetic mice. Front Immunol. 2021;12:633540.CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Wan H, et al. Associations between the neutrophil-to-lymphocyte ratio and Diabetic complications in adults with diabetes: a cross-sectional study. J Diabetes Res. 2020;2020:p6219545.CrossRef Wan H, et al. Associations between the neutrophil-to-lymphocyte ratio and Diabetic complications in adults with diabetes: a cross-sectional study. J Diabetes Res. 2020;2020:p6219545.CrossRef
Metadaten
Titel
Effect of neutrophil to lymphocyte ratio on prognosis of elderly patients with severe sepsis combined with diabetes mellitus
verfasst von
Shan Jin
Jun-bin Yin
Wei Li
Li-li Zang
Publikationsdatum
01.12.2024
Verlag
BioMed Central
Erschienen in
BMC Geriatrics / Ausgabe 1/2024
Elektronische ISSN: 1471-2318
DOI
https://doi.org/10.1186/s12877-024-04757-0

Weitere Artikel der Ausgabe 1/2024

BMC Geriatrics 1/2024 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Bei Herzinsuffizienz muss „Eisenmangel“ neu definiert werden!

16.05.2024 Herzinsuffizienz Nachrichten

Bei chronischer Herzinsuffizienz macht es einem internationalen Expertenteam zufolge wenig Sinn, die Diagnose „Eisenmangel“ am Serumferritin festzumachen. Das Team schlägt vor, sich lieber an die Transferrinsättigung zu halten.

Herzinfarkt mit 85 – trotzdem noch intensive Lipidsenkung?

16.05.2024 Hypercholesterinämie Nachrichten

Profitieren nach einem akuten Myokardinfarkt auch Betroffene über 80 Jahre noch von einer intensiven Lipidsenkung zur Sekundärprävention? Um diese Frage zu beantworten, wurden jetzt Registerdaten aus Frankreich ausgewertet.

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Erstmanifestation eines Diabetes-Typ-1 bei Kindern: Ein Notfall!

16.05.2024 DDG-Jahrestagung 2024 Kongressbericht

Manifestiert sich ein Typ-1-Diabetes bei Kindern, ist das ein Notfall – ebenso wie eine diabetische Ketoazidose. Die Grundsäulen der Therapie bestehen aus Rehydratation, Insulin und Kaliumgabe. Insulin ist das Medikament der Wahl zur Behandlung der Ketoazidose.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.